A delegation from Teva Research and Development Center paid a visit to SIAIS at ShanghaiTech University on January 26. SIAIS Vice Director Yang Guang gave them a warm welcome. Dr. Steffen Nock, who is Global Head of Biological Preparation Department at Teva Pharmaceutical Industries described the company’s profile and the recent progress of the R&D center. Dr. Daniella Gutman, the director of R&D for Israel, Vice President for TevaPharmaceutical China Mr. Reshef and Ms. Julan Ren, BD Director at Teva China also talked about the recent progress of the R&D Center and expressed interest in the research direction like antibody.
Moreover, the distinguished professor Nicola Elvassore, visiting professor Fabio Mammano, CO-PI Nie Yan and Associate Research ProfessorLiu Jia on behalf of their respective labs of SIAIS and introduced the general situation and field. Subsequently, the two sides had a broad and in depth exchange of views, and they visited our institute.
Teva Pharmaceutical Industries is the world's leading generic pharmaceutical company. It is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients (APIs). The company conducts its operations in the Americas, Europe, Asia and other regions of the world.